FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159514587> ?p ?o ?g. }

• W2159514587 endingPage "2206" @default.
• W2159514587 startingPage "2199" @default.
• W2159514587 abstract "An imbalance between neutrophil extracellular trap (NET) formation and degradation has been described in systemic lupus erythematosus (SLE), potentially contributing to autoantigen externalisation, type I interferon synthesis and endothelial damage. We have demonstrated that peptidylarginine deiminase (PAD) inhibition reduces NET formation and protects against lupus-related vascular damage in the New Zealand Mixed model of lupus. However, another strategy for inhibiting NETs--knockout of NOX2--accelerates lupus in a different murine model, MRL/lpr. Here, we test the effects of PAD inhibition on MRL/lpr mice in order to clarify whether some NET inhibitory pathways may be consistently therapeutic across models of SLE.NET formation and autoantibodies to NETs were characterised in lupus-prone MRL/lpr mice. MRL/lpr mice were also treated with two different PAD inhibitors, Cl-amidine and the newly described BB-Cl-amidine. NET formation, endothelial function, interferon signature, nephritis and skin disease were examined in treated mice.Neutrophils from MRL/lpr mice demonstrate accelerated NET formation compared with controls. MRL/lpr mice also form autoantibodies to NETs and have evidence of endothelial dysfunction. PAD inhibition markedly improves endothelial function, while downregulating the expression of type I interferon-regulated genes. PAD inhibition also reduces proteinuria and immune complex deposition in the kidneys, while protecting against skin disease.PAD inhibition reduces NET formation, while protecting against lupus-related damage to the vasculature, kidneys and skin in various lupus models. The strategy by which NETs are inhibited will have to be carefully considered if human studies are to be undertaken." @default.
• W2159514587 created "2016-06-24" @default.
• W2159514587 creator A5010407321 @default.
• W2159514587 creator A5021554993 @default.
• W2159514587 creator A5040865874 @default.
• W2159514587 creator A5045690232 @default.
• W2159514587 creator A5059551211 @default.
• W2159514587 creator A5062407111 @default.
• W2159514587 creator A5085330501 @default.
• W2159514587 creator A5086184942 @default.
• W2159514587 creator A5088056432 @default.
• W2159514587 date "2014-08-07" @default.
• W2159514587 modified "2023-10-17" @default.
• W2159514587 title "Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/<i>lpr</i> mice" @default.
• W2159514587 cites W1502316154 @default.
• W2159514587 cites W1503053236 @default.
• W2159514587 cites W1534043095 @default.
• W2159514587 cites W1547552531 @default.
• W2159514587 cites W1805954825 @default.
• W2159514587 cites W1924968745 @default.
• W2159514587 cites W1968564077 @default.
• W2159514587 cites W1987218634 @default.
• W2159514587 cites W1992687368 @default.
• W2159514587 cites W2003394446 @default.
• W2159514587 cites W2006953158 @default.
• W2159514587 cites W2016561383 @default.
• W2159514587 cites W2019916852 @default.
• W2159514587 cites W2026847731 @default.
• W2159514587 cites W2032600290 @default.
• W2159514587 cites W2035806483 @default.
• W2159514587 cites W2042214412 @default.
• W2159514587 cites W2047849952 @default.
• W2159514587 cites W2064373716 @default.
• W2159514587 cites W2066700680 @default.
• W2159514587 cites W2067022007 @default.
• W2159514587 cites W2067106263 @default.
• W2159514587 cites W2070324798 @default.
• W2159514587 cites W2070811352 @default.
• W2159514587 cites W2076718946 @default.
• W2159514587 cites W2080882856 @default.
• W2159514587 cites W2083420798 @default.
• W2159514587 cites W2087999363 @default.
• W2159514587 cites W2096015012 @default.
• W2159514587 cites W2097957649 @default.
• W2159514587 cites W2099356583 @default.
• W2159514587 cites W2102162665 @default.
• W2159514587 cites W2104934425 @default.
• W2159514587 cites W2107666116 @default.
• W2159514587 cites W2109178826 @default.
• W2159514587 cites W2110994039 @default.
• W2159514587 cites W2125613887 @default.
• W2159514587 cites W2126026783 @default.
• W2159514587 cites W2126774943 @default.
• W2159514587 cites W2132116387 @default.
• W2159514587 cites W2134595043 @default.
• W2159514587 cites W2135849676 @default.
• W2159514587 cites W2140499012 @default.
• W2159514587 cites W2142360671 @default.
• W2159514587 cites W2150031910 @default.
• W2159514587 cites W2154243191 @default.
• W2159514587 cites W2157558787 @default.
• W2159514587 cites W2161083956 @default.
• W2159514587 cites W2162154761 @default.
• W2159514587 cites W2179862924 @default.
• W2159514587 cites W2316480313 @default.
• W2159514587 doi "https://doi.org/10.1136/annrheumdis-2014-205365" @default.
• W2159514587 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4320672" @default.
• W2159514587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25104775" @default.
• W2159514587 hasPublicationYear "2014" @default.
• W2159514587 type Work @default.
• W2159514587 sameAs 2159514587 @default.
• W2159514587 citedByCount "304" @default.
• W2159514587 countsByYear W21595145872015 @default.
• W2159514587 countsByYear W21595145872016 @default.
• W2159514587 countsByYear W21595145872017 @default.
• W2159514587 countsByYear W21595145872018 @default.
• W2159514587 countsByYear W21595145872019 @default.
• W2159514587 countsByYear W21595145872020 @default.
• W2159514587 countsByYear W21595145872021 @default.
• W2159514587 countsByYear W21595145872022 @default.
• W2159514587 countsByYear W21595145872023 @default.
• W2159514587 crossrefType "journal-article" @default.
• W2159514587 hasAuthorship W2159514587A5010407321 @default.
• W2159514587 hasAuthorship W2159514587A5021554993 @default.
• W2159514587 hasAuthorship W2159514587A5040865874 @default.
• W2159514587 hasAuthorship W2159514587A5045690232 @default.
• W2159514587 hasAuthorship W2159514587A5059551211 @default.
• W2159514587 hasAuthorship W2159514587A5062407111 @default.
• W2159514587 hasAuthorship W2159514587A5085330501 @default.
• W2159514587 hasAuthorship W2159514587A5086184942 @default.
• W2159514587 hasAuthorship W2159514587A5088056432 @default.
• W2159514587 hasBestOaLocation W21595145872 @default.
• W2159514587 hasConcept C126322002 @default.
• W2159514587 hasConcept C134018914 @default.
• W2159514587 hasConcept C134897094 @default.
• W2159514587 hasConcept C159654299 @default.
• W2159514587 hasConcept C163764329 @default.
• W2159514587 hasConcept C203014093 @default.

• next